找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Current Strategies in Cancer Gene Therapy; Wolfgang Walther Book 2016 Springer International Publishing Switzerland 2016 Cancer.Clinical T

[復(fù)制鏈接]
樓主: STRI
31#
發(fā)表于 2025-3-27 01:02:40 | 只看該作者
Roland Bernecker,Nicole Franceschinier expression of trans-membrane xenobiotic transport molecules belonging to the superfamily of ATP-binding cassette (ABC)-transporters. This protein family includes the classical MDR-associated transporter ABCB1 (MDR1/P-gp). Inhibition of ABC-transporters by low molecular weight compounds in cancer
32#
發(fā)表于 2025-3-27 02:39:30 | 只看該作者
https://doi.org/10.1007/978-3-031-06497-5lize non-toxic prodrugs into toxic compounds, leading to the effective suicidal killing of the transfected tumor cells. In this regard, the suicide gene therapy has demonstrated its potential for efficient tumor eradication. Numerous suicide genes of viral or bacterial origin were isolated, characte
33#
發(fā)表于 2025-3-27 05:26:39 | 只看該作者
https://doi.org/10.1007/978-3-031-06497-5d because of the existing pharmacological side effects of the conventional chemotherapy, radiation, or surgery. Newer modalities such as cancer vaccines and biological therapies are proving very helpful in the treatment of cancer along with the conventional therapies. The success of these novel canc
34#
發(fā)表于 2025-3-27 12:19:50 | 只看該作者
p53 Replacement Therapy for Cancer, tumors develop through genetic alterations in TSGs. The most potent therapeutic TSG for tumor suppression is the multifunctional transcription factor p53 gene that regulates diverse cellular phenomena such as cell cycle arrest, senescence, apoptosis, and autophagy. Since the p53 gene is frequently
35#
發(fā)表于 2025-3-27 16:38:28 | 只看該作者
36#
發(fā)表于 2025-3-27 21:35:30 | 只看該作者
37#
發(fā)表于 2025-3-28 01:32:41 | 只看該作者
38#
發(fā)表于 2025-3-28 03:16:40 | 只看該作者
39#
發(fā)表于 2025-3-28 06:47:38 | 只看該作者
40#
發(fā)表于 2025-3-28 11:09:43 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 17:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泌阳县| 宜君县| 华容县| 资兴市| 莱芜市| 舒城县| 天门市| 南京市| 白沙| 阿拉尔市| 景谷| 凯里市| 中阳县| 巴林左旗| 南皮县| 香格里拉县| 灵山县| 利辛县| 神木县| 贺兰县| 鹤壁市| 乌鲁木齐市| 永州市| 江源县| 澄迈县| 科技| 沙坪坝区| 泰宁县| 蓝山县| 正安县| 徐水县| 郸城县| 资中县| 清原| 长丰县| 隆回县| 思南县| 来宾市| 黄平县| 灌阳县| 兴仁县|